INTRODUCTION
METHODS Expression and molecular cloning studies have resulted in Materials the identification of two distinct peptide transporters in rabbit (1) (2) (3) , rat (4) (5) (6) and human (7, 8) . The localization of PEPT1 [ 14 C]Glycylsarcosine (GlySar; 119 mCi/mmol) was pur-(in intestine and kidney) and PEPT2 (in kidney) are consistent chased from Amersham (Chicago, IL). Captopril was obtained with their physiological roles in absorbing small peptides arising from Sigma Chemical Co (St. Louis, MO). Quinapril was a gift from Parke-Davis (Ann Arbor, MI) and enalapril from Merck (Rahway, NJ). Collagenase A was purchased from Boehringer Mannheim (Indianapolis, IN). Other chemicals were 1 College of Pharmacy and Upjohn Center for Clinical Pharmacology, obtained from standard sources and were of the highest qualThe University of Michigan, Ann Arbor, Michigan 48109. ity available. A rat duodenal cDNA library (18) was screened using a legeville, Pennsylvania 19426.
0.62 kb PEPT1 probe generated by specific PCR primers. In 4 To whom correspondence should be addressed at 4302A Upjohn a similar manner, a rat kidney cortex gt10 cDNA library (19) Center, 1310 E. Catherine Street, The University of Michigan, Ann was screened using a specific 0.52 kb PEPT2 probe. The full- immunolocalization studies (17) .
Uptake Studies in Xenopus Oocytes
Xenopus laevis oocytes were prepared as described prewhere v represents the uptake rate, Vmax is the maximal rate viously (21), except that oocytes were defolliculated by incubatof uptake, Km is the Michaelis constant, and C is the substrate ing them in calcium-free Barth's solution containing (GlySar) concentration. Quinapril inhibited the uptake of Glycollagenase (3 mg/ml) at 18ЊC for 3-3.5 hours. Capped cRNAs Sar in a noncompetitive manner (see Results section). For transof rat PEPT1 and PEPT2 were synthesized by in vitro transcripport in the presence of a noncompetitive inhibitor, the tion and mature oocytes were injected with 50 nl of each transLineweaver-Burk transformation gives: porter (10 ng for PEPT1 or 15 ng for PEPT2). Control oocytes were injected with 50 nl of deionized water. Oocytes were 1 v ϭ 1 Vmax
(2) maintained at 18ЊC in Barth's solution supplemented with 50 g/ml gentamicin, and 100 g/ml each of penicillin and streptomycin. Uptake studies were carried out 3 days after injection. where Ki is the inhibition constant and I is the inhibitor concenThe research adhered to the "Principles of Laboratory Animal tration. Likewise, for noncompetitive inhibition the Dixon Care" (NIH publication #85-23, revised 1985).
plot gives: Oocytes were incubated with radiolabeled GlySar (Ϯ ACE inhibitors) for 1 hour at room temperature in a buffer that contained (in mM): NaCl, 100; KCl, 2; MgCl 2 , 1; CaCl 2 , 1;
Mes, 3; Tris, 3; Hepes, 3; adjusted to pH 6.0 with Tris. Following several rinses with ice-cold washing solution (i.e., uptake solution Tris adjusted to pH 7.5), individual oocytes were dissolved In contrast, enalapril inhibited the uptake of GlySar in a competin 250 l of 10% SDS, mixed with 2.5 ml of scintillation itive manner (see Results section) and, as a result, the Linewcocktail, and the radioactivity measured by liquid scintillation eaver-Burk and Dixon plots become: counting. Uptake rates of GlySar into water-injected oocytes were always subtracted from uptake rates in oocytes expressing rat PEPT1 or PEPT2. These experimental conditions were opti-
mized based on the results of preliminary studies. Likewise, dipeptide uptake was linear over a 1-hour time period (data not shown).
Electrophysiology Studies in Xenopus Oocytes
Ki was estimated for quinapril and enalapril by two different approaches: i) by linear regression of Lineweaver-Burk plots Steady-state currents were evaluated using a conventional expressed by Equations 2 and 4, respectively and ii) by linear two-microelectrode voltage-clamp method, as described pre-regression of Dixon plots expressed by Equations 3 and 5, viously (19, 20) . Uptake solutions (as described for inhibition respectively. studies, pH 6.0) were used for extracellular perfusion at approximately 1.5 ml/min. After 3-5 minutes of membrane potential RESULTS stabilization following microelectrode impalements, the oocyte membrane potential was clamped at Ϫ50 mV. When recording Concentration-Dependent Uptake of GlySar currents at a holding potential, digitalization at 0.5 s/sample
The initial rate uptake of radiolabeled GlySar was evaluand filtering at 20 Hz were used. Substrate-induced currents ated as a function of increasing concentrations of unlabeled were then evaluated, at room temperature, as the difference dipeptide in cRNA-injected rat PEPT1 or PEPT2 Xenopus between currents recorded before and after substrate addition.
oocytes. As shown in Fig. 1 , these studies demonstrate that GlySar has a low-affinity for PEPT1 (Km ϭ 237 Ϯ 30 M,
Data Analysis
Vmax ϭ 1263 Ϯ 239 pmol/oocyte/hr; r 2 Ն 0.991) relative to PEPT2 (Km ϭ 22.3 Ϯ 1.2 M, Vmax ϭ 212 Ϯ 35 pmol/ Unless otherwise specified, results are reported as mean oocyte/hr; r 2 Ն 0.990) and that the differences in affinity are Ϯ SD. In an experiment, each data point reflects 4-9 oocytes substantial (i.e., 10-fold). Moreover, a linear transformation of obtained from at least two different donors. Statistical differthe data ( Fig. 1 inserts) indicates that GlySar interacts with a ences among treatment groups were evaluated by analysis of single transporter. Overall, the results are consistent with PEPT1 variance (ANOVA) and pairwise comparisons were made using being a high-capacity, low-affinity symporter whereas PEPT2 Tukey's test (␣ ϭ 0.05). All statistical computations were pertransports small peptides with low-capacity but high-affinity. formed using SYSTAT v5.03 (Systat, Inc., Evanston, IL). NonThese findings plus dose-response analyses with quinapril and linear as well as linear regression analyses were conducted enalapril (data not shown) were then used to guide subsequent using Scientist v2.01 (MicroMath Scientific Software, Salt Lake experiments probing the mechanism of inhibition for each ACE City, UT) and a weighting factor of unity. The quality of the inhibitor (as described below). fit was determined by evaluating the coefficient of determination (r 2 ), the standard deviation of parameter estimates, and by Inhibition Studies visual inspection of the residuals.
The saturation kinetics of GlySar (Ϯ inhibitors) have been In Xenopus oocytes expressing rat PEPT1 or PEPT2, quinapril resulted in changes in the slope and y-intercept of the described previously (14, 15) . Briefly, Fig. 2 . Lineweaver-Burk analyses of the effect of quinapril on GlySar uptake in Xenopus oocytes expressing rat PEPT1 (2A and 2B) or PEPT2 (2C and 2D). Uptake studies were carried out 3 days after oocytes were cRNA-injected with 10 ng of PEPT1 or 15 ng of PEPT2. The one-hour uptake of radiolabeled GlySar (2.7-55.9 M) Ϯ quinapril (0-1.0 mM) was determined at room temperature in pH 6.0 buffer. Fig. 1 . Saturable uptake of GlySar in Xenopus oocytes expressing rat All data were corrected for the uptake in water-injected oocytes, and PEPT1 (1A) or PEPT2 (1B). Uptake studies were carried out 3 days are expressed as mean Ϯ SE from 3 separate experiments. Lines were after oocytes were cRNA-injected with 10 ng of PEPT1 or 15 ng of generated using fitted mean parameters (see Table I ), as determined PEPT2. The one-hour uptake of radiolabeled GlySar (5.9 M) Ϯ by linear regression analysis. unlabeled dipeptide (0-10 mM for PEPT1 or 0-1.0 mM for PEPT2) was determined at room temperature in pH 6.0 buffer. All data were corrected for the uptake in water-injected oocytes, and are expressed as mean Ϯ SE from 3 separate experiments. The line was generated the slopes of these same curves vs. 1/GlySar have a y-intercept using fitted mean parameters (see text), as determined by nonlinear that is significant. Regardless of the method used (Table I) In Xenopus oocytes expressing rat PEPT1 or PEPT2, the effect of enalapril was in sharp contrast to that of quinapril. Thus, enalapril addition revealed changes in the slope and xintercept of Lineweaver-Burk plots, but not in the y-intercept Lineweaver-Burk plots, but not the x-intercept values ( for PEPT2). Kinetic analyses (Table II) were consistent with a result, kinetic analyses (Table I) 89.5 to 93.9 pmol/oocyte/hr for PEPT2). A competitive inhibistudied with quinapril (169 to 177 M for PEPT1; 23.1 to 26.3 M for PEPT2). These results demonstrate that the interaction tion of GlySar by enalapril was also supported by Dixon plot analyses (Figs. 5A and 5B for PEPT1; Figs. 5C and 5D for between quinapril and GlySar for both rat PEPT1 and PEPT2 was noncompetitive. Further evidence for a noncompetitive PEPT2). For both transporters, the curves (1/uptake vs. inhibitor) intersect above the x-axis and the slopes of these same inhibition was provided by Dixon plot analyses. As shown in Figs. 3A and 3B (for PEPT1) and Figs. 3C and 3D (for PEPT2), curves vs. 1/GlySar form a line that goes right through the origin. Ki estimates for enalapril were consistent between the the curves (1/uptake vs. inhibitor) intersect on the x-axis, and two methods tested, and were about 10.8 mM for PEPT1 and The electrogenic uptake of ACE inhibitors (i.e., captopril, (0-1.0 mM) was determined at room temperature in pH 6.0 buffer. quinapril, enalapril) was evaluated in rat PEPT1-and PEPT2-All data were corrected for the uptake in water-injected oocytes, and expressed oocytes under voltage-clamp conditions. As shown are expressed as mean Ϯ SE from 3 separate experiments. Lines were in Fig. 6 , inwardly-directed currents were induced by 10 mM generated using fitted mean parameters (see Table I ), as determined captopril in both PEPT1-and PEPT2-expressed oocytes. Appli-by linear regression analysis. cation of 1.2 mM quinapril in the presence of 10 mM captopril substantially decreased these currents. In addition, quinapril alone did not evoke inward currents. These data demonstrate underlying this apparent selectivity. Thus, it is generally believed that quinapril is a non-transported inhibitor of both peptide that in contrast to the intestinal transporter PEPT1, ACE inhibitors transporters. Note that quinapril induced small outward currents and ␤-lactam antibiotics without an ␣-amino side chain are not in the absence of external substrate for both PEPT1 and PEPT2 substrates for the renal homologue PEPT2. This opinion was based (Fig. 6) . In fact, in the absence of external substrate, PEPT2 largely on inhibition and electrophysiology studies in Xenopus was shown to mediate small uncoupled proton influxes (proton oocytes expressing rabbit PEPT1 or PEPT2. In the first study (1), leak, see reference 20) that were inhibited by 1.2 mM of quinthe transport of 1 mM radiolabeled cefadroxil (in pH 6.5 buffer) april. Taken together, quinapril inhibited both cotransport and was cis-inhibited by 10 mM of enalapril or captopril, but not uncoupled proton leak mediated by PEPT1 or PEPT2. In conlisinopril, in rabbit PEPT1 cRNA-injected oocytes. This finding trast, enalapril was capable of inducing concentration-depenwas confirmed by a rapid depolarization of the membrane potential dent currents for both rat PEPT1 (Vmax ϭ 55.2 Ϯ 5.9 nA, in oocytes being bathed with 2 mM of captopril. However, in the Km ϭ 15.7 Ϯ 3.3 mM; r 2 Ն 0.989) and PEPT2 (Vmax ϭ second study (2), 5 mM of captopril or enalapril failed to cis-13.9 Ϯ 3.9 nA, Km ϭ 1.2 Ϯ 0.2 mM; r 2 Ն 0.969), as shown inhibit the uptake of 25 M radiolabeled cefadroxil (in pH 6.0 in Fig. 7 , indicating that enalapril is a transportable substrate.
buffer) in oocytes expressing rabbit PEPT2. Subsequent to these Moreover, enalapril appears to have a greater affinity for PEPT2 experiments, studies in rabbit renal brush border membrane vesias compared to PEPT1 (p Ͻ 0.001). For all studies, ACE cles (BBMV) have demonstrated that a wide variety of ACE inhibitors had no significant effect on control (waterinhibitors can interact with the high-affinity peptide carrier in injected) oocytes.
kidney (14, 15) . It was also observed that while quinapril was a noncompetitive inhibitor of GlySar, enalapril inhibited the uptake DISCUSSION of GlySar in a competitive manner. These latter studies suggested that enalapril was a substrate for PEPT2 and that quinapril could Conflicting data have been reported regarding the selective transport of ACE inhibitors by PEPT1 and PEPT2, and the reason inhibit but was not, in itself, transported. However, renal BBMV PEPT2. In the absence of external substrate, an inward quinapril-
The one-hour uptake of radiolabeled GlySar (3.0-25.9 M) Ϯ enalapril sensitive proton current (i.e., proton leak) was also observed in (0-10 mM) was determined at room temperature in pH 6.0 buffer. All data were corrected for the uptake in water-injected oocytes, and are oocytes expressing PEPT2 and, to a lesser extent, PEPT1. This expressed as mean Ϯ SE from 3 separate experiments. Lines were finding, together with a noncompetitive mechanism of inhibition, generated using fitted mean parameters (see Table II ), as determined suggests that quinapril may adversely affect the binding and/or by linear regression analysis. translocation of at least one proton with the transporter, as described previously for the rat PEPT2 protein (20) . Given the large degree of structural similarity between quinapril and enalapril, it is curious why these two ACE inhibitors are handled so differently experiments are limited in that they do not allow for the individual by the H + -coupled peptide symporters. While enalapril has a evaluation of PEPT1 and PEPT2. In addition, due to the unavailproline moiety at the carboxyl end of its peptidomimetic structure, ability of radiolabeled ACE inhibitor, direct evidence for transport this group is replaced in quinapril by tetrahydroisoquinolinecaris lacking. boxylic acid. Although speculative, it is possible that additional In the present study, the differential mechanism of dipeptide steric or hydrophobic interactions may occur, because of this inhibition by quinapril and enalapril was clearly demonstrated substitution, such that quinapril binds to PEPT1 and PEPT2 in in Xenopus oocytes injected with rat PEPT1-or PEPT2-cRNA.
such a way that cotransport is conformationally unfavorable. For Quinapril noncompetitively inhibited the transport of GlySar in the same reason, captopril can be transported by both peptide oocytes expressing PEPT1 (Ki Ϸ 0.8 mM) while enalapril was transporters since it too has a proline group at its carboxyl terminus. a competitive inhibitor under similar experimental conditions Ultimately, confirmation of this issue will require a deeper analysis (Ki Ϸ 10.8 mM). Likewise, quinapril was a noncompetitive inhibiof the structure-activity relationship of these compounds. tor of GlySar transport in oocytes expressing PEPT2 (Ki Ϸ 0.4 ACE inhibitors are important therapeutic agents for treatmM) while enalapril displayed a competitive inhibition under ing patients with hypertension and cardiovascular diseases. similar conditions (Ki Ϸ 4.3 mM). These results demonstrate Since these drugs are administered orally and have local (i.e., that ACE inhibitors exhibit low-affinity interactions with both renal) actions in addition to systemic effects, it is crucial to oligopeptide transporters, and that not all ACE inhibitors (e.g., understand the mechanisms by which ACE inhibitors are transquinapril) are substrates for PEPT1 and/or PEPT2.
ported across brush border membranes in the intestine and Direct evidence for transport of some ACE inhibitors by kidney. At usual therapeutic doses, ACE inhibitors reach mM either rat PEPT2 or PEPT1 was afforded by the electrophysiology concentrations in the intestine and, in doing so, achieve levels experiments performed with captopril, quinapril and enalapril. In at which they may compete with other substrates for PEPT1 this regard, convincing evidence was provided for the electrogenic uptake. At these same doses, ACE inhibitors are likely to be and concentration-dependent uptake of captopril and enalapril by both oligopeptide transporters. On the other hand, quinapril was present in the renal tubular lumen at low M concentrations Fig. 5 . Dixon plots of the effect of enalapril on the kinetics of GlySar uptake in Xenopus oocytes expressing rat PEPT1 (5A and 5B) or PEPT2 (5C and 5D). Uptake studies were carried out 3 days after oocytes were cRNA-injected with 10 ng of PEPT1 or 15 ng of PEPT2. The one-hour uptake of radiolabeled GlySar (3.0-25.9 M) Ϯ enalapril (0-10 mM) was determined at room temperature in pH 6.0 buffer. All data were corrected for the uptake in water-injected oocytes, and are expressed as mean Ϯ SE from 3 separate experiments. Lines were generated using fitted mean parameters (see Table II ), as determined by linear regression analysis. and, consequently, their ability to inhibit PEPT2-mediated reab-captopril and/or quinapril in Xenopus oocytes expressing rat PEPT1 (6A) or PEPT2 (6B). Similar results were observed in additional oocytes sorption of peptides and peptide-like drugs is small. In contrast, (n ϭ 4 for PEPT1 or PEPT2). Using the two-microelectrode voltagepeptide-bound amino acids (i.e., di-and tripeptides) are filtered clamp method, currents were measured at Ϫ50 mV in pH 6.0 buffer at the glomerulus in high M to mM concentrations (22) and, at room temperature. Studies were performed 3 days after oocytes were as a result, may compete with ACE inhibitors to minimize drug cRNA-injected with 10 ng of PEPT1 or 15 ng of PEPT2. Water-injected reabsorption in the kidney. However, the extent of ACE inhibitor oocytes did not display a significant response in current to the addition uptake (i.e., reabsorption as well as absorption) is uncertain in of ACE inhibitors. vivo, as well as the role of oligopeptide transporters relative to other carrier-mediated and passive components. Further, a lack of information regarding the actual concentrations of naturallyoccurring peptides at transporting sites, the residence times in that it argues against a free ␣-amino group as being an absolute a particular region during the sequential transport of substrate requirement for substrate recognition by the high-affinity transalong the nephron, the modulating effect of peptidases in the porter in kidney, PEPT2. We also demonstrate that not all ACE luminal brush border, and the presence of both PEPT1 and inhibitors (e.g., quinapril) are uniformly transported across the PEPT2 in kidney make predictions difficult. Perhaps, with the intestine or kidney by H + -coupled peptide transporters. These development of transgenic knockout mice, more definitive observations point to differences between PEPT1 and PEPT2 in answers can be obtained concerning the significance of PEPT1 their affinity to, rather than in their specificity for, ACE inhibitors. and PEPT2 in influencing the physiological uptake of peptides and peptidomimetic drugs in the intestine and kidney. ACKNOWLEDGMENTS In summary, our studies demonstrate for the first time the direct electrogenic uptake of captopril and enalapril in Xenopus
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